Abstract: The disclosure provides IL-7 fusion proteins as well as compositions comprising them. The disclosure further provides methods of treating and/or preventing lymphopenia or immunodeficiency in a subject, wherein the method includes administering a fusion protein as described herein.

Abstract: A method for correcting projection images in CT image reconstruction is provided. The method may include obtaining a plurality of projection images of a subject. Each of the plurality of projection images may correspond to one of the plurality of gantry angles. The method may further include correcting a first projection image of the plurality of projection images according to a process for generating a corrected projection image. The process may include performing, based on the first projection image and a second projection image of the plurality of projection images, a first correction on the first projection image to generate a preliminary corrected first projection image. The process may also include performing, based on at least part of the preliminary corrected first projection image, a second correction on the preliminary corrected first projection image to generate a corrected first projection image corresponding to the first gantry angle.

Abstract: This application relates to the field of terminal device technologies, and provides a vibration motor and a terminal device, to reduce a thickness of a terminal device without sacrificing performance of a vibration motor. The terminal device includes a first screen, a first middle frame, and a vibration motor. At least a part of the first screen is located on one side of the first middle frame and is stacked with the first middle frame. The vibration motor is located on a side that is of the first middle frame and that is away from the at least part of the first screen. The vibration motor includes a housing, one end of the housing is opened to form an opening, the opening faces the first middle frame, and an edge of the housing at the opening is fastened to the first middle frame. The terminal device provided in embodiments of this application is used in a communications system.

Abstract: Provided is a humanized anti-CD22 recombinant immunotoxin, which has reduced immunogenicity and maintains the CD22 binding affinity and corresponding biological activity before humanization transformation, and is used for preparing a drug for treating CD22-related B cell malignant tumors.

Abstract: Provided in the present invention is an isolated anti-CD22 antibody or an antigen-binding fragment thereof, and further provided is the use thereof. The antibody or the antigen binding fragment thereof shows strong identification capability for and a high affinity to CD22 recombinant protein and a CD22 positive cell line, a strong internalization capability to enter the CD22 positive cell line, and an effective growth inhibition and cell apoptosis effect on the CD22 positive cell line after fusion with bacterial exotoxin.

Abstract: A glycosylation-modified erythropoietin, containing a glycan structure incorporated into an N-glycosylation site, wherein the glycan structure contains FA4G4L2S4.

Abstract: A method for correcting projection images in CT image reconstruction is provided. The method may include obtaining a plurality of projection images of a subject. Each of the plurality of projection images may correspond to one of the plurality of gantry angles. The method may further include correcting a first projection image of the plurality of projection images according to a process for generating a corrected projection image. The process may include performing, based on the first projection image and a second projection image of the plurality of projection images, a first correction on the first projection image to generate a preliminary corrected first projection image. The process may also include performing, based on at least part of the preliminary corrected first projection image, a second correction on the preliminary corrected first projection image to generate a corrected first projection image corresponding to the first gantry angle.

Abstract: The present disclosure discloses a method for expressing and preparing a bivalent bispecific antibody. In the present disclosure, each portion of a bivalent bispecific antibody and an immune hybrid protein thereof is respectively expressed in a suitable prokaryotic or eukaryotic cell system, separated and purified by high-performance affinity chromatography, and then spliced in vitro by trans-splicing reaction mediated by an intein, to prepare the bivalent specific antibody and an immune hybrid protein thereof.

Abstract: A method for correcting projection images in CT image reconstruction is provided. The method may include obtaining a plurality of projection images of a subject. Each of the plurality of projection images may correspond to one of the plurality of gantry angles. The method may further include correcting a first projection image of the plurality of projection images according to a process for generating a corrected projection image. The process may include performing, based on the first projection image and a second projection image of the plurality of projection images, a first correction on the first projection image to generate a preliminary corrected first projection image. The process may also include performing, based on at least part of the preliminary corrected first projection image, a second correction on the preliminary corrected first projection image to generate a corrected first projection image corresponding to the first gantry angle.

Abstract: Provided is a polypeptide combination, a targeting component thereof comprising a shielding peptide, a cleavable part, an antigen-binding part and a first intein fragment, the shielding peptide and the antigen-binding part being connected by means of the cleavable part, and the antigen-binding part being directly or indirectly connected to the first intein fragment; a toxin component thereof comprises a second intein fragment and a toxin, and the second intein fragment is directly or indirectly connected to the toxin; the targeting component and the toxin component form an immunoconjugate by means of the interactive action between the first intein fragment and the second intein fragment; in the immunoconjugate, the shielding peptide and the antigen-binding part are connected by means of the cleavable part, and the antigen-binding part is connected to the toxin. Also provided are a preparation method and a pharmaceutical use for the polypeptide combination.

Abstract: A polypeptide composition, and methods of making the same, may include a first polypeptide and a second polypeptide, wherein the first polypeptide comprise a first toxin fragment and a first intein fragment, the second polypeptide comprise a second toxin fragment and a second intein fragment, the first polypeptide is different from the second polypeptide; the first toxin fragment and the second toxin fragment are non-biotoxic; the first polypeptide and the second polypeptide may make the first toxin fragment and the second toxin fragment into biotoxic toxins by means of the interaction of the first intein fragment and the second intein fragment. Kits may include such first and second polypeptides, and such compositions and kits may be used in treating tumors.

Abstract: This application provides a power supply system for a terminal device, and a chip, and relates to the charging field. The power supply system includes a battery pack, a bypass circuit, a voltage step-down circuit, and a controller. The battery pack includes at least two batteries. The controller is configured to: when the batteries in the battery pack need to be switched to a series mode, control the voltage step-down circuit to work and control the bypass circuit to stop working, and is further configured to: when the batteries in the battery pack need to be switched to a parallel mode, control the bypass circuit to work and control the voltage step-down circuit to stop working. In the system, switching between the series mode and the parallel mode can be automatically implemented based on an actual situation, so that endurance and stability of the terminal device are improved.

Abstract: Methods for preparing a recombinant protein from a bacterium are provided. The method includes constructing an expression vector including two promoters. Each of the two promoters attaches a secretion signal peptide to one polypeptide of a protein. The protein attached with the two promoters and secretion signal peptides is then cloned into the expression vector to provide a recombinant expression plasmid. The recombinant expression plasmid is transformed into a host cell. A fermentation process is performed to grow the host cell and to induce an expression to synthesize polypeptides in the host cell and to transport the polypeptides to an outside of a cytoplasm of the host cell, such that the polypeptides are released in a soluble form in a growth medium of the host cell. The polypeptides are assembled into a three-dimensional structure of the protein. The protein is captured from the growth medium.

Abstract: The present disclosure relates to the technical field of lithium-ion battery, and particularly, to an electrolytic solution and a lithium-ion battery including the electrolytic solution. The electrolytic solution includes additives, and the additives include an additive A and an additive B. The additive A forms a film on the surface of the positive electrode and effectively prevents interface side reactions at the positive electrode. Comparing with the additive A, the additive B is preferentially reduced to form a film at the negative electrode, avoiding an increase in impedance and deterioration of cycling dynamic performance, etc., caused by film formation of the additive A on the negative electrode. The combination of the additive A and additive B imparts the battery with a reduced gas production, a higher capacity retention rate and a lower impedance at high temperature.

Abstract: A method for correcting projection images in CT image reconstruction is provided. The method may include obtaining a plurality of projection images of a subject. Each of the plurality of projection images may correspond to one of the plurality of gantry angles. The method may further include correcting a first projection image of the plurality of projection images according to a process for generating a corrected projection image. The process may include performing, based on the first projection image and a second projection image of the plurality of projection images, a first correction on the first projection image to generate a preliminary corrected first projection image. The process may also include performing, based on at least part of the preliminary corrected first projection image, a second correction on the preliminary corrected first projection image to generate a corrected first projection image corresponding to the first gantry angle.

Abstract: This application relates to the field of batteries, and in particular, to an electrolytic solution and a lithium-ion battery, a battery module, a battery pack and an apparatus that adopt the electrolytic solution. This application provides an electrolytic solution, including an electrolyte and a solvent, and further including an additive A and an additive B. The additive A is selected from at least one of compounds whose chemical structural formula is denoted by Formula I, and the additive B is selected from at least one of compounds whose chemical structural formula is denoted by Formula II. By using the additive A and the additive B together, this application enables films to be formed on surfaces of a positive electrode plate and a negative electrode plate concurrently, thereby significantly improving cycle performance and high-temperature storage performance of the lithium-ion battery, and also ensuring excellent kinetic performance of the lithium-ion battery.

Abstract: The present invention discloses a Lithium ion battery and an electrolyte thereof, the electrolyte comprising an organic solvent, a lithium salt and an additive. The additive comprises a cyclic fluoro carbonate (A), a cyclic phosphazene (B), a cyclic sulfate and a lithium fluoro oxalate borate (D). The lithium fluoro oxalate borate (D) has following formula: Compared with the prior art, the electrolyte of the present invention may form a stable CEI and SEI film on the surface of positive and negative electrodes, protect the interface between positive and negative electrodes, improve the acidic atmosphere of Lithium ion battery electrolyte, and reduce the damage effect of HF on the interface between positive and negative electrodes, while reducing low temperature resistance of lithium-ion battery, improving cycle life, high temperature storage performance, safety performance and rate capability of lithium-ion battery.

Abstract: A method for correcting projection images in CT image reconstruction is provided. The method may include obtaining a plurality of projection images of a subject. Each of the plurality of projection images may correspond to one of the plurality of gantry angles. The method may further include correcting a first projection image of the plurality of projection images according to a process for generating a corrected projection image. The process may include performing, based on the first projection image and a second projection image of the plurality of projection images, a first correction on the first projection image to generate a preliminary corrected first projection image. The process may also include performing, based on at least part of the preliminary corrected first projection image, a second correction on the preliminary corrected first projection image to generate a corrected first projection image corresponding to the first gantry angle.

Abstract: The present invention discloses a Lithium ion battery and an electrolyte thereof, the electrolyte comprising an organic solvent, a lithium salt and an additive. The additive comprises additive (A) cyclic fluoro carbonate, additive (B) cyclic phosphazene (B), and additive (C) cyclic sulfate. The additive B cyclic phosphazene has the following general structural formula: Compared with the prior art, the electrolyte of the present invention may form a stable CEI and SEI film on the surface of positive and negative electrodes, protect the interface between positive and negative electrodes, improve the acidic atmosphere of Lithium ion battery electrolyte, and reduce the damage effect of HF on the interface between positive and negative electrodes, thereby improving cycle life, high temperature storage performance, and safety performance of lithium-ion battery.

Abstract: The present disclosure relates to the field of biological technologies, and discloses a method for expressing and preparing a polyvalent multi-specific antibody and an immune hybrid protein. By using the characteristics of protein Intein, a novel method for preparing a polyvalent specific antibody, a hybrid immune protein having an antibody fused to a cytokine, an immunotoxin having an antibody fused to a toxin, or an immune hybrid protein having an antibody fused to other active proteins is designed and developed. Each portion of a hybrid protein is respectively expressed in a suitable prokaryotic or eukaryotic cell system, separated and purified by high-performance affinity chromatography, and then spliced in vitro by trans-splicing mediated by the intein, to prepare a polyvalent specific antibody and an immune hybrid protein. The method has high production efficiency, and wide scope of application, and facilitates the separation and purification of the products.